LeMaitre Vascular Files 8-K on Financials
Ticker: LMAT · Form: 8-K · Filed: Aug 5, 2025 · CIK: 1158895
| Field | Detail |
|---|---|
| Company | Lemaitre Vascular Inc (LMAT) |
| Form Type | 8-K |
| Filed Date | Aug 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, sec-filing
Related Tickers: LMAT
TL;DR
LMAT filed an 8-K on Aug 5th about their financials. Details TBD.
AI Summary
On August 5, 2025, LeMaitre Vascular, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or operational details were disclosed in the provided text.
Why It Matters
This filing indicates that LeMaitre Vascular is providing updates on its financial performance and condition to the SEC, which is important for investors to monitor the company's health.
Risk Assessment
Risk Level: low — The filing is a standard disclosure of financial information and does not contain any immediately apparent negative news or significant changes.
Key Players & Entities
- LeMaitre Vascular, Inc. (company) — Registrant
- August 5, 2025 (date) — Date of Report
- 001-33092 (other) — Commission File Number
- 63 Second Avenue Burlington, MA 01803 (address) — Principal executive offices
FAQ
What specific financial results or conditions are being reported by LeMaitre Vascular?
The provided text of the 8-K filing does not specify the details of the results of operations or financial condition being reported.
What is the purpose of this 8-K filing for LeMaitre Vascular?
The purpose of this 8-K filing is to report on the company's Results of Operations and Financial Condition, as well as to provide Financial Statements and Exhibits.
When was this 8-K report filed?
This 8-K report was filed on August 5, 2025.
What is LeMaitre Vascular's principal executive office address?
LeMaitre Vascular's principal executive office is located at 63 Second Avenue, Burlington, MA 01803.
Does the filing indicate any significant changes or events beyond routine financial reporting?
Based on the provided text, the filing appears to be a standard report on financial condition and results of operations, with no specific mention of other significant events.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 5, 2025 regarding LEMAITRE VASCULAR INC (LMAT).